CD274 and neoplasm: Treatment of Anti-PD-L1 Refractory MOC1 Tumors With Non-Replicative Ad5-CMV-mTNFα/mIL-2 Improves the Metabolic Profile of Tumor-Infiltrating-Lymphocytes